Check out our most popular compounded medications! Get Started
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded suspension containing cimetidine hydrochloride, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing cimetidine are listed in tablet and solution forms. No cimetidine product of any kind is listed in suspension form.
Liquid bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.
Cimetidine is an H2-receptor antagonist that lowers stomach acid; compounding pharmacies prepare it as oral liquids, capsules and other forms by prescription.
Cimetidine is a histamine H2-receptor antagonist. It competitively blocks histamine at H2 receptors on the parietal cells of the stomach, reducing both daytime and nighttime acid secretion; it is not an anticholinergic. Manufactured prescription cimetidine tablets (for example Mylan) are FDA-approved for short-term treatment of active duodenal ulcer, maintenance therapy after a duodenal ulcer heals, short-term treatment of active benign gastric ulcer, erosive gastroesophageal reflux disease, and pathological hypersecretory conditions such as Zollinger-Ellison syndrome. A prescription oral solution is also manufactured, and cimetidine is sold over the counter as Tagamet HB to prevent and treat heartburn. Prescribers may order cimetidine compounded when a patient needs a strength, flavor, dye-free vehicle or dosage form that no manufactured product offers. Compounded preparations are not FDA-approved and require a prescription.
The cimetidine tablet label has no boxed warning. Avoid it if you are allergic to it. Cimetidine slows the liver's breakdown of several medicines, including warfarin, phenytoin, theophylline, lidocaine, propranolol, nifedipine, diazepam, chlordiazepoxide, certain tricyclic antidepressants and metronidazole, which can raise their blood levels; people taking warfarin need closer clotting checks. Antacids can reduce its absorption, and it can reduce absorption of ketoconazole. Reversible confusion has been reported, mostly in severely ill patients, adults 50 and older, and people with liver or kidney disease. Breast enlargement can occur with a month or more of use. The label notes there are no adequate studies in pregnancy, and because cimetidine passes into breast milk it advises against nursing while taking it as a general rule; LactMed says it is not expected to harm a breastfed infant, although other drugs might be preferred because of its effect on liver enzymes. For confusion or other side effects, talk to your prescriber or pharmacist.
Cimetidine competitively inhibits basal, nocturnal and food-stimulated acid secretion. Per the Mylan label, oral absorption is rapid with peak levels at 45 to 90 minutes, the half-life is about 2 hours, the sulfoxide is the major metabolite, and urine is the principal route of excretion, with 48 percent of an oral dose recovered unchanged at 24 hours. StatPearls reports a volume of distribution near 1 L/kg and plasma protein binding near 20 percent, and describes inhibition of CYP1A2, CYP2C9, CYP2D6 and CYP3A4; it advises avoiding dofetilide and eliglustat. Labeled indications (cimetidine tablets): active duodenal ulcer and maintenance, active benign gastric ulcer, erosive GERD, and pathological hypersecretory conditions. StatPearls lists off-label uses of cimetidine including recalcitrant warts, chronic idiopathic urticaria, postburn pruritus and PFAPA syndrome; none of these is an FDA-approved indication. Dosing is per prescriber, with renal impairment considered. Monitor renal function, mental status in older adults (StatPearls notes Beers criteria advise avoiding H2 blockers in older adults because of delirium risk), levels or effects of interacting narrow-therapeutic-index drugs, and vitamin B12 with long-term use. The label describes a weak antiandrogenic effect and gynecomastia. Cimetidine is not a controlled substance.
Shake the bottle well before every dose so the medication is evenly mixed. Measure with the oral syringe or dosing cup provided, using the milliliter markings, and never a kitchen spoon. Take it by mouth as your label directs. Rinse the syringe after use and recap the bottle.
Water-based suspensions are aqueous preparations. Under USP <795>, a preserved suspension usually carries a beyond-use date of up to 35 days at room temperature or refrigerated; an unpreserved one is refrigerated for up to 14 days. Oil-based suspensions are nonaqueous and may carry up to 90 days. Your label states storage and the beyond-use date. Keep out of reach of children and discard after that date.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
